Authors:
Mata, JF
Garcia-Manteiga, JM
Lostao, MP
Fernandez-Veledo, S
Guillen-Gomez, E
Larrayoz, IM
Lloberas, J
Casado, FJ
Pastor-Anglada, M
Citation: Jf. Mata et al., Role of the human concentrative nucleoside transporter (hCNT1) in the cytotoxic action of 5[prime]-deoxy-5-fluorouridine, an active intermediate metabolite of capecitabine, a novel oral anticancer drug, MOLEC PHARM, 59(6), 2001, pp. 1542-1548
Authors:
Oshinski, JN
Yang, ZQ
Jones, JR
Mata, JF
French, BA
Citation: Jn. Oshinski et al., Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging, CIRCULATION, 104(23), 2001, pp. 2838-2842
Authors:
Hagspiel, KD
Altes, TA
Mugler, JP
Spellman, MJ
Mata, JF
Tustison, NJ
Brookeman, JR
Citation: Kd. Hagspiel et al., MR virtual colonography using hyperpolarized He-3 as an endoluminal contrast agent: Demonstration of feasibility, MAGN RES M, 44(5), 2000, pp. 813-816
Authors:
Lostao, MP
Mata, JF
Larrayoz, IM
Inzillo, SM
Casado, FJ
Pastor-Anglada, M
Citation: Mp. Lostao et al., Electrogenic uptake of nucleosides and nucleoside-derived drugs by the human nucleoside transporter 1 (hCNT1) expressed in Xenopus laevis oocytes, FEBS LETTER, 481(2), 2000, pp. 137-140